Circumcision Device

A field-by-field file-review guide for medical device distributors, OEM buyers, and hospital procurement teams evaluating sterile single-use suppliers after 2 February 2026: why 21 CFR 820.70, 820.75, and 820.80 are reserved, what ISO 13485 Clause 7.5 and 21 CFR 820.45 mandate for production, process validation, and labeling inspection, and how FDA Compliance Program 7382.850 audits Production and Service Provision.

An operational regulatory guide for international medical device distributors, OEM buyers and manufacturers placing sterile single-use devices on the Republic of Korea market under the Medical Devices Act, Enforcement Rule Article 65 fees, and Act No. 21263 QMS conformity rules.

An incoming audit guide for medical device distributors, OEMs, and hospital procurement teams: why 21 CFR 820.100 and 820.198 are reserved under QMSR, how ISO 13485 Clauses 8.2.2, 8.3, 8.5.2, and 8.5.3 carry the legal duties, what 21 CFR 820.35 adds on top, what CP 7382.850 inspects under Measurement, Analysis, and Improvement, why an MDR report is not the complaint file, and a 7-point buyer acceptance protocol.

A definitive, decision-led guide for international manufacturers and Singapore distributors: navigating Singapore Health Sciences Authority (HSA) medical device registration, SMDR listings, Class A SHARE notifications, Registrant mandates, dealer licences, GN-15 R13 evaluation pathways, and 2026 fee cards.

A register-first supplier map that separates brands, legal manufacturers, sterilizers, listing establishments, certificate holders and distributors before an RFQ is issued.

A practical buyer's audit guide for medical device purchasing and outsourcing files: why 21 CFR 820.50 is reserved under QMSR, how ISO 13485 Clauses 4.1.5 and 7.4 carry the legal duties, what FDA Compliance Program 7382.850 inspects, why supplier-audit reports are no longer exempt, and a 7-point incoming acceptance checklist.

An operational decision guide for international medical-device distributors, private-label/OEM buyers, and overseas manufacturers: navigating Health Canada Medical Device Licences (MDL) under SOR/98-282 s 26, Medical Device Establishment Licences (MDEL) under GUI-0016 Table 1, the mandatory MDSAP quality filing condition, Schedule 1 risk classification, official 1 April 2026 fees including the private-label MDL, MDALL versus MDEL listing verification boundaries, and the SOR/2026-110 modernization coming-into-force timeline.

An operational decision guide for international distributors, private-label/OEM buyers, and overseas manufacturers: navigating Australian Register of Therapeutic Goods (ARTG) inclusion under the Therapeutic Goods Act 1989, the Australian sponsor mandate, Manufacturer Evidence pre-approval, TGA risk classification (Classes I, IIa, IIb, III), Comparable Overseas Regulator (COR) pathways, July 2026 fee schedules, and the class-phased 1 July 2026 Unique Device Identification (AusUDID) rollout.

A practical buyer's audit guide for medical device risk management files: separating ISO 13485 QMSR process mandates from ISO 14971 conformity, verifying EN ISO 14971:2019+A11:2021 for EU MDR, navigating China's GB/T 42062-2022, and executing a 7-point incoming acceptance protocol.

An operational decision guide for international distributors, private-label/OEM buyers, and overseas manufacturers: navigating the Kingdom of Saudi Arabia's MDMA requirements under Law M/54, the Technical File Assessment route, SFDA Classes A–D (MDS-G008), the May 2025 fee schedule, the 3 May 2026 bundling criteria (MDS-G028), Authorized Representative mandates, importer establishment licensing, and port-clearance verification.

An operational decision guide for international distributors, OEM buyers, and non-UK manufacturers: navigating Great Britain's CE-recognition timelines (2028 vs 2030), UKCA requirements under UK MDR 2002, UK Responsible Person mandates, DORS registration and 2026 fees, Northern Ireland EUDAMED rules, and the in-force June 2025 post-market surveillance obligations.

A practical five-check verification workflow, Annex XII reading grid, NANDO designation guide, EUDAMED status decoder, and distribution-agreement schedule for international distributors qualifying European medical-device suppliers.

A multi-jurisdiction regulatory matrix and distributor evidence checklist comparing US 21 CFR 884.4530, EU MDR Class IIa Rule 6, China provincial Class II NMPA registrations, and WHO prequalification gates.

An original FDA surveillance analysis of 31 circumcision device 510(k) clearances, 34 recalls, and 942 MAUDE adverse-event reports (all-time; 592 in the 2015–2026 window) translated into tender acceptance criteria and supplier-vigilance questions for disposable circumcision stapler, ring, and clamp devices.

A component-level technical guide to the single-use circumcision anastomat and stapler: the bell-and-staple firing mechanism, what belongs in the sterile convenience kit, the staple-formation and sterile-barrier lot-acceptance tests, and the US, EU and China classification — including why no US 510(k) predicate and no WHO prequalification exist for the stapler.

A practical audit and qualification checklist for distributors and private-label buyers evaluating circumcision device manufacturers, distinguishing ISO 13485 from product-specific CE certificates, defining legal-manufacturer obligations, and protecting territory exclusivity.

A B2B procurement framework for turning ex-works device quotes into defensible landed-cost-per-unit figures, incorporating size-mix MOQ, sterile packaging, tariff treatment, customs classification, and lot-release terms.

Qualifying a radiation-sterilized single-use device OEM requires verifying an ISO 11137 validation protocol, substantiating the 25 kGy or 15 kGy sterilization dose via VDmax, selecting the optimal modality (gamma vs e-beam vs X-ray), capping polymer maximum doses, and aligning with the 4-month dose-audit interval under ISO 11137-1:2025 and the FDA Radiation Master File Pilot.

Matching device mechanics to clinical throughput, establishing adult and pediatric size ladders, and verifying FDA, CE, and NMPA registration evidence.

How single-use rings, circular staplers and disposable-suture kits turned a 20-minute scalpel-and-suture operation into a roughly 7-minute sutureless one — an Asia-led device shift the world adopted before the US FDA recorded it.